Perspective Therapeutics (CATX) Raw Materials (2011 - 2023)

Perspective Therapeutics has disclosed Raw Materials across 11 years of filings, most recently posting $764000.0 for Q3 2023.

• In Q3 2023, Raw Materials fell 16.23% year-over-year to $764000.0; the TTM figure through Sep 2023 stood at $764000.0 (down 16.23% YoY), while the FY2022 annual figure was $752000.0, changed N/A from the prior year.
• Raw Materials came in at $764000.0 for Q3 2023 at Perspective Therapeutics, down from $781000.0 in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $912000.0 in Q3 2022 to a low of $330000.0 in Q3 2019.
• Average Raw Materials over 5 years is $598105.3, with a median of $645000.0 recorded in 2021.
• Year-over-year, Raw Materials surged 98.69% in 2021 and dropped 16.23% in 2023.
• Over 5 years, Raw Materials stood at $372000.0 in 2019, then advanced by 20.43% to $448000.0 in 2020, then jumped by 67.63% to $751000.0 in 2021, then grew by 0.13% to $752000.0 in 2022, then grew by 1.6% to $764000.0 in 2023.
• Per Business Quant data, the three most recent Raw Materials figures were $764000.0 in Q3 2023, $781000.0 in Q2 2023, and $777000.0 in Q1 2023.